Diffuse Large B-Cell Lymphoma — Trials

Diffuse Large B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 355
Recruiting: 190
Ph III recruiting: 16
Growth YoY: −11.6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (177)

clinicaltrialsPublishedShowing 151–200 of 1,150 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07478848	Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas	recruiting	Phase 1	14	Abramson Cancer Center at Penn MedicineOTHER	1	Jul 1, 2026	clinicaltrials
NCT05653271	ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies	completed	Phase 1	16	Acepodia Biotech, Inc.INDUSTRY	3	Jun 30, 2026	clinicaltrials